Your browser doesn't support javascript.
loading
[Efficacy of Hyper-CVAD/MA and CHALL-01 regimens in the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia patients under 60 years old].
Huang, A J; Wang, L B; Du, J; Tang, G S; Cheng, H; Gong, S L; Gao, L; Qiu, H Y; Ni, X; Chen, J; Chen, L; Zhang, W P; Wang, J M; Yang, J M; Hu, X X.
Afiliación
  • Huang AJ; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Wang LB; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Du J; Department of Hematology, Changzheng Hospital, Second Military Medical University, Shanghai 200433, China.
  • Tang GS; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Cheng H; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Gong SL; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Gao L; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Qiu HY; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Ni X; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Chen J; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Chen L; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Zhang WP; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Wang JM; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Yang JM; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
  • Hu XX; Department of Hematology, Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
Zhonghua Xue Ye Xue Za Zhi ; 40(8): 625-632, 2019 Aug 14.
Article en Zh | MEDLINE | ID: mdl-31495127
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromosoma Filadelfia / Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans / Middle aged Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromosoma Filadelfia / Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans / Middle aged Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: China